BOYDSENSE
Financials
Estimates*
USD | 2022 | 2023 |
---|---|---|
Revenues | <1m | <1m |
% growth | - | 83 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
€2.5m | Grant | ||
$9.5m | Early VC | ||
* | €7.0m | Early VC | |
Total Funding | $20.0m |
Recent News about BOYDSENSE
EditBOYDSense, an award-winning startup with R&D in France and the U.S., is a pioneer in the development of non-invasive breath analysis solutions for the risk stratification, screening, monitoring and detection of different biomarkers.
BOYDSense is currently developing its first product, a miniaturized breath analyzer for monitoring glucose concentration in pre-diabetics and type 2 diabetics. The device detects the type and concentration of volatile organic compounds in breath. The solution is pain-free, affordable, and produces significantly less waste compared to existing fingerstick blood glucose or continuous glucose monitors.
Keywords: Healthcare, Medical Devices, Breath Analysis, Chronic Conditions, Diagnostics, Disease screening, Diabetes Monitoring Device, Health Information, Health Monitoring Device.